AnnouncementsArvind Remedies to consider dividend
100% of moneycontrol users recommend buying Arvind Remedies. What's your call on Arvind Remedies today? Read 8 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2542.00||-1.38||2939.80||1901.00||43,241.67|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Arvind Remedies is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 296.35 crore.The company has reported a standalone sales of Rs 233.04 crore and a Net Profit of Rs 18.61 crore for the quarter ended Dec 2013.
The company management includes B Arvind Shah - Managing Director & CEO, Chandra Ravindran - Whole Time Director, C M K Reddy - Director, R Raja Mohan - Director, V R Mehta - Director, Ankur Agarwal - Executive Director, Sudhir Chandra - Additional Director.
It is listed on the BSE with a BSE Code of 531823 and the NSE with an NSE Code of ARVINDREM.
Its Registered office is at 190, Poonamallee High Road , Chennai (Madras),Tamil Nadu - 600084.
Their Registrars are Cameo Corporate Services Ltd.